Processed xenogenic cartilage as innovative biomatrix for cartilage tissue engineering: Effects on chondrocyte differentiation and function

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 12, 2015, Pages E239-E251

  Schwarz, Silke ^a   Elsaesser, Alexander F ^a   Koerber, Ludwig ^b   Goldberg Bockhorn, Eva ^a   Seitz, Andreas M ^c   Bermueller, Christian ^a   Dürselen, Lutz ^c   Ignatius, Anita ^c   Breiter, Roman ^b   Rotter, Nicole ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

3D cell culture; Cartilage reconstruction; Cartilage tissue engineering; Cell differentiation; Extracellular matrix; Xenogenic implant matrix

Indexed keywords

BODY FLUIDS; CELL ADHESION; CELL CULTURE; CELL ENGINEERING; COLLAGEN; ENZYME ACTIVITY; GENE EXPRESSION; IMAGE RECONSTRUCTION; MICROSTRUCTURE; TISSUE ENGINEERING;

3-D CELL CULTURE; CARTILAGE RECONSTRUCTION; CARTILAGE TISSUE ENGINEERING; CELL DIFFERENTIATION; CHONDROCYTES; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX PROTEIN; IMPLANT MATRIX; MATRIX; XENOGENIC IMPLANT MATRIX;

CARTILAGE;

COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; SCLEROPROTEIN;

ARTICLE; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DECELLULARIZATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMPLANT; INSTRUMENT STERILIZATION; NASAL SEPTAL CARTILAGE; PRIORITY JOURNAL; TISSUE ENGINEERING; UPREGULATION; XENOGENIC CARTILAGE; ADOLESCENT; ADULT; AGED; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL CULTURE TECHNIQUE; CHEMISTRY; CHONDROCYTE; CYTOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; NOSE SEPTUM; PIG; PROCEDURES;

ADOLESCENT; ADULT; AGED; ANIMALS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL SEPTUM; SWINE; TISSUE ENGINEERING;

EID: 84955179731     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1650     Document Type: Article

References (66)

1. Acharya C, Adesida A, Zajac P et al. 2012; Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol 227: 88-97.
2. Aigner T, Stove J. 2003; Collagens - major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Deliv Rev 55: 1569-1593.
3. Barbosa I, Garcia S, Barbier-Chassefiere V et al. 2003; Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13: 647-653.
4. Bartlett W, Skinner JA, Gooding CR et al. 2005; Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br 87: 640-645.
5. Bauman PA, Lawrence LA, Biesert L et al. 2006; Critical factors influencing prion inactivation by sodium hydroxide. Vox Sang 91: 34-40.
6. Borovec S, Broumis C, Adcock W et al. 1998; Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat. Biologicals 26: 237-244.
7. Brandl A, Angele P, Roll C et al. 2010; Influence of the growth factors PDGF-BB, TGFβ1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J Orthop Res 28: 354-360.
8. Breiter R, Körber L, Schwarz S. 2010a; Collagen implant. Patent Application No. WO/2010/108945A1.
9. Breiter R, Körber L, Schwarz S. 2010b; Collagen implant. Patent Application No. EP2411453A1.
10. Brittberg M, Lindahl A, Nilsson A et al. 1994; Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
11. Buschmann MD, Soulhat J, Shirazi-Adl A et al. 1998; Confined compression of articular cartilage: linearity in ramp and sinusoidal tests and the importance of interdigitation and incomplete confinement. J Biomech 31: 171-178.
12. Candrian C, Vonwil D, Barbero A et al. 2008; Engineered cartilage generated by nasal chondrocytes is responsive to physical forces resembling joint loading. Arthritis Rheum 58: 197-208.
13. Cao Y, Vacanti JP, Paige KT et al. 1997; Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 100: 297-302.
14. Chia SH, Schumacher BL, Klein TJ et al. 2004; Tissue-engineered human nasal septal cartilage using the alginate-recovered chondrocyte method. Laryngoscope 114: 38-45.
15. Darling EM, Athanasiou KA. 2005; Growth factor impact on articular cartilage subpopulations. Cell Tissue Res 322: 463-473.
16. Duda GN, Haisch A, Endres M et al. 2000; Mechanical quality of tissue engineered cartilage: results after 6 and 12weeks in vivo. J Biomed Mater Res 53: 673-677.
17. Ernst DR, Race RE. 1993; Comparative analysis of scrapie agent inactivation methods. J Virol Methods 41: 193-201.
18. Glowacki J, Mizuno S. 2008; Collagen scaffolds for tissue engineering. Biopolymers 89: 338-344.
19. Haisch A, Duda GN, Schroeder D et al. 2005; The morphology and biomechanical characteristics of subcutaneously implanted tissue-engineered human septal cartilage. Eur Arch Otorhinolaryngol 262: 993-997.
20. Hattori S, Adachi E, Ebihara T et al. 1999; Alkali-treated collagen retained the triple helical conformation and the ligand activity for the cell adhesion via α2β1 integrin. J Biochem 125: 676-684.
21. Homicz MR, Chia SH, Schumacher BL et al. 2003; Human septal chondrocyte redifferentiation in alginate, polyglycolic acid scaffold, and monolayer culture. Laryngoscope 113: 25-32.
22. Homicz MR, Schumacher BL, Sah RL et al. 2002; Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg 127: 398-408.
23. Kafienah W, Jakob M, Demarteau O et al. 2002; Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng 8: 817-826.
24. Kasermann F, Kempf C. 2003; Sodium hydroxide renders the prion protein PrPSc sensitive to proteinase K. J Gen Virol 84: 3173-3176.
25. Kim YJ, Sah RL, Doong JY et al. 1988; Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174: 168-176.
26. Kon M, de Visser AC. 1981; A poly(HEMA) sponge for restoration of articular cartilage defects. Plast Reconstr Surg 67: 288-294.
27. Kusuhara H, Isogai N, Enjo M et al. 2009; Tissue engineering a model for the human ear: assessment of size, shape, morphology, and gene expression following seeding of different chondrocytes. Wound Repair Regen 17: 136-146.
28. Langer R, Vacanti JP. 1993; Tissue engineering. Science 260: 920-926.
29. Liese J, Marzahn U, El Sayed K et al. 2012; Cartilage tissue engineering of nasal septal chondrocyte macroaggregates in human demineralized bone matrix. Cell Tissue Bank [epub ahead of print].
30. Lin Z, Fitzgerald JB, Xu J et al. 2008; Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 26: 1230-1237.
31. Lin Z, Willers C, Xu J et al. 2006; The chondrocyte: biology and clinical application. Tissue Eng 12: 1971-1984.
32. Mafi P, Hindocha S, Mafi R et al. 2012; Evaluation of biological protein-based collagen scaffolds in cartilage and musculoskeletal tissue engineering - a systematic review of the literature. Curr Stem Cell Res Ther 7: 302-309.
33. Mallein-Gerin F, Garrone R, van der Rest M. 1991; Proteoglycan and collagen synthesis are correlated with actin organization in dedifferentiating chondrocytes. Eur J Cell Biol 56: 364-373.
34. Mandl EW, Jahr H, Koevoet JL et al. 2004; Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture. Matrix Biol 23: 231-241.
35. Nagata S. 1994; Modification of the stages in total reconstruction of the auricle: Part I. Grafting the three-dimensional costal cartilage framework for lobule-type microtia. Plast Reconstr Surg 93: 221-230.
36. Naumann A, Dennis JE, Aigner J et al. 2004; Tissue engineering of autologous cartilage grafts in three-dimensional in vitro macroaggregate culture system. Tissue Eng 10: 1695-1706.
37. Naumann A, Rotter N, Bujia J et al. 1998; Tissue engineering of autologous cartilage transplants for rhinology. Am J Rhinol 12: 59-63.
38. Nehrer S, Breinan HA, Ramappa A et al. 1997a; Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res 38: 95-104.
39. Nehrer S, Breinan HA, Ramappa A et al. 1997b; Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes. Biomaterials 18: 769-776.
40. Nooeaid P, Salih V, Beier JP et al. 2012; Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med 16: 2247-2270.
41. Nuernberger S, Cyran N, Albrecht C et al. 2011; The influence of scaffold architecture on chondrocyte distribution and behavior in matrix-associated chondrocyte transplantation grafts. Biomaterials 32: 1032-1040.
42. O'Brien FJ, Harley B, Yannas IV et al. 2005; The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26: 433-441.
43. Ohara K, Nakamura K, Ohta E. 1997; Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting. Plast Reconstr Surg 99: 1030-1036.
44. Peterson L, Brittberg M, Kiviranta I et al. 2002; Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30: 2-12.
45. Pieper JS, van der Kraan PM, Hafmans T et al. 2002; Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials 23: 3183-3192.
46. Richmon JD, Sage AB, Shelton E et al. 2005; Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer. Laryngoscope 115: 1553-1560.
47. Rotter N, Aigner J, Naumann A et al. 1999; Behavior of tissue-engineered human cartilage after transplantation into nude mice. J Mater Sci Mater Med 10: 689-693.
48. Rotter N, Bucheler M, Haisch A et al. 2007; Cartilage tissue engineering using resorbable scaffolds. J Tissue Eng Regen Med 1: 411-416.
49. Rotter N, Haisch A, Bucheler M. 2005; Cartilage and bone tissue engineering for reconstructive head and neck surgery. Eur Arch Otorhinolaryngol 262: 539-545.
50. Ryan MW, Quinn FB Jr. 2007; Advancing otolaryngology education in the new millennium. Otolaryngol Clin North Am 40: 1191, 4, v.
51. Schnabel M, Marlovits S, Eckhoff G et al. 2002; Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthr Cartilage 10: 62-70.
52. Schuh E, Hofmann S, Stok K et al. 2012; Chondrocyte redifferentiation in 3D: the effect of adhesion site density and substrate elasticity. J Biomed Mater Res A 100: 38-47.
53. Schuh E, Hofmann S, Stok KS et al. 2011; The influence of matrix elasticity on chondrocyte behavior in 3D. J Tissue Eng Regen Med 6: e31-42.
54. Schuh E, Kramer J, Rohwedel J et al. 2010; Effect of matrix elasticity on the maintenance of the chondrogenic phenotype. Tissue Eng Part A 16: 1281-1290.
55. Schwarz S, Koerber L, Elsaesser AF et al. 2012; Decellularized cartilage as a novel biomatrix for cartilage tissue engineering applications. Tissue Eng Part A 18: 2195-2209.
56. Stone KR, Rodkey WG, Webber RJ et al. 1990; Future directions. Collagen-based prostheses for meniscal regeneration. Clin Orthop Relat Res 252: 129-135.
57. Taguchi F, Tamai Y, Uchida K et al. 1991; Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol 119: 297-301.
58. Tay AG, Farhadi J, Suetterlin R et al. 2004; Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng 10: 762-770.
59. Tew SR, Hardingham TE. 2006; Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J Biol Chem 281: 39471-39479.
60. Tuli R, Li WJ, Tuan RS. 2003; Current state of cartilage tissue engineering. Arthritis Res Ther 5: 235-238.
61. Unal A, Thyer J, Uren E et al. 2007; Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie. Biologicals 35: 161-164.
62. Vacanti CA, Langer R, Schloo B et al. 1991; Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 88: 753-759.
63. Van Osch GJ, Marijnissen WJ, van der Veen SW et al. 2001; The potency of culture-expanded nasal septum chondrocytes for tissue engineering of cartilage. Am J Rhinol 15: 187-192.
64. Vickery K, Deva AK, Zou J et al. 1999; Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing. J Hosp Infect 41: 317-322.
65. Vinatier C, Gauthier O, Fatimi A et al. 2009; An injectable cellulose-based hydrogel for the transfer of autologous nasal chondrocytes in articular cartilage defects. Biotechnol Bioeng 102: 1259-1267.
66. Wang JH, Lee BJ, Jang YJ. 2007; Use of silicone sheets for dorsal augmentation in rhinoplasty for Asian noses. Acta Otolaryngol Suppl 558: 115-120.